Study guide

11.3 Pediatric Acute Respiratory Distress Syndrome (PARDS) & Severe Pneumonia

Neonatal Pediatric Transport C-NPT

Track your progress as you read

Finished sections get a check mark.

1 Introduction: The C-NPT Exam

About the C-NPT Exam: 2026 Format, Eligibility & Content Outline

2 Chapter 1: Transport Systems, Regulatory Framework & Legal Issues

1.1 Transport System Architecture, Accreditation (CAMTS) & Dispatch Triage 1.2 Regulatory & Legal Mandates: EMTALA, HIPAA, Consent & Documentation 1.3 Medical Direction, Scope of Practice & Ethical Considerations

3 Chapter 2: Safety, Communication, Crew Resource Management & Transport Environment

2.1 Crew Resource Management (CRM), Situational Awareness & Sterile Cockpit 2.2 Aircraft & Ground Ambulance Operations, Landing Zones & Vehicle Dynamics 2.3 Environmental Hazards, Weather Minimums & In-Flight Emergency Procedures 2.4 Communication in Transport: Peer Handoffs, Age-Appropriate Care, Families & Crew Stressors 2.5 Infection Control, PPE, Scene Safety & Disaster/Evacuation Planning

4 Chapter 3: Flight Physiology & Environmental Stressors

3.1 Physical Gas Laws & Transport Implications (Boyle, Dalton, Charles, Henry, Graham) 3.2 Altitude Hypoxia, Barometric Pressure Changes & Dysbarism 3.3 Acceleration Forces (G-forces), Vibration & Acoustic Stress in Transit 3.4 Thermoregulation Physics & Neutral Thermal Environment in Transit

5 Chapter 4: Invasive Procedures & Transport Monitoring

4.1 Advanced Airway Management & Endotracheal Intubation in Transit 4.2 Pleural Decompression (Needle Thoracostomy & Chest Tube Management) 4.3 Vascular Access: Umbilical Lines (UAC/UVC), Intraosseous (IO) & Arterial Lines

6 Chapter 5: Transport Equipment, Respiratory Physiology & Mechanical Ventilation

5.1 Transport Incubators (Isolettes), Thermal Control & Electrical/Gas Power Systems 5.2 Portable Ventilators & Modes (PC, VC, PRVC, High Frequency) 5.3 Gas Cylinder Duration Calculations, Oxygen Delivery & Inhaled Nitric Oxide (iNO) 5.4 Respiratory Physiology: Acid-Base Balance, Oxygenation, Lung Mechanics & Troubleshooting

7 Chapter 6: Transport Pharmacology, Resuscitation, Fluids & Electrolytes

6.1 Vasoactive Infusions & Inotropes (Epinephrine, Dopamine, Dobutamine, Milrinone) 6.2 Sedation, Analgesia & Neuromuscular Blockade in Transport 6.3 Prostaglandin E1 (Alprostadil) & Surfactant Replacement Therapy 6.4 Resuscitation Protocols (NRP, PALS) & Shock Fluid Resuscitation 6.5 Antimicrobial Pharmacology in Neonatal & Pediatric Transport 6.6 Post-Resuscitation Care, Defibrillation & Cardioversion in Transit, ECMO Indications & the Transport-vs-Stay Decision 6.7 Fluid & Electrolyte Therapy Across the Ages: Maintenance, Dehydration, Fluid Overload & Electrolyte Emergencies

8 Chapter 7: Neonatal Respiratory Pathologies & Management

7.1 Respiratory Distress Syndrome (RDS) & Surfactant Deficiency 7.2 Meconium Aspiration Syndrome (MAS) & Persistent Pulmonary Hypertension (PPHN) 7.3 Transient Tachypnea (TTN), Neonatal Pneumothorax & Congenital Diaphragmatic Hernia (CDH) 7.4 Neonatal Upper Airway Anomalies, Aspiration, Pneumonia, Chronic Lung Disease & Respiratory Failure

9 Chapter 8: Neonatal Cardiovascular Critical Care

8.1 Ductal-Dependent Cyanotic Congenital Heart Defects (TGA, TOF, Tricuspid Atresia) 8.2 Ductal-Dependent Systemic Blood Flow Lesions (HLHS, Coarctation, Interrupted Arch) 8.3 Neonatal Arrhythmias, Cardiogenic Shock & Post-Resuscitation Care 8.4 Acyanotic Congenital Heart Lesions, Patent Ductus Arteriosus, Obstructed TAPVR & Neonatal Heart Failure

10 Chapter 9: Neonatal Neurological & Metabolic Crises

9.1 Hypoxic-Ischemic Encephalopathy (HIE) & Passive/Active Therapeutic Hypothermia 9.2 Neonatal Seizures & Intraventricular Hemorrhage (IVH) 9.3 Neonatal Hypoglycemia, Electrolyte Derangements & Hyperbilirubinemia 9.4 Subgaleal Hemorrhage, Neonatal Sepsis & Meningitis, and Perinatal Substance Exposure (NOWS)

11 Chapter 10: Neonatal Surgical Emergencies, Neural Tube Defects & ELBW Care

10.1 Abdominal Wall Defects (Gastroschisis vs. Omphalocele) & TEF/Esophageal Atresia 10.2 Necrotizing Enterocolitis (NEC), Malrotation with Volvulus & Intestinal Obstruction 10.3 Care of the Extremely Low Birth Weight (ELBW) Infant (<1000g) in Transit 10.4 Neural Tube Defects: Myelomeningocele, Encephalocele & Transport of the Newborn With an Open Spinal Defect

12 Chapter 11: Pediatric Respiratory Emergencies

11.1 Acute Upper Airway Obstruction (Croup, Epiglottitis, Bacterial Tracheitis, Foreign Body) 11.2 Lower Airway Crises: Status Asthmaticus & Severe Bronchiolitis 11.3 Pediatric Acute Respiratory Distress Syndrome (PARDS) & Severe Pneumonia

13 Chapter 12: Pediatric Shock & Cardiovascular Crises

12.1 Pathophysiology & Transport Management of Pediatric Septic Shock 12.2 Hypovolemic, Cardiogenic & Anaphylactic Shock in Children 12.3 Pediatric Cardiac Emergencies: SVT, Ventricular Arrhythmias & Myocarditis 12.4 Pediatric Cardiovascular Crises: Palliated Congenital Heart Disease, Pulmonary Hypertensive Crisis, Pericarditis & Tamponade, Hypertensive Emergency & Anterior Mediastinal Mass

14 Chapter 13: Pediatric Neurological Emergencies & Trauma

13.1 Status Epilepticus, Altered Mental Status & Meningitis/Encephalitis 13.2 Pediatric Traumatic Brain Injury (TBI) & Increased Intracranial Pressure (ICP) 13.3 Blunt/Penetrating Trauma, Spinal Motion Restriction & Thermal Burns 13.4 Non-Accidental Trauma, Smoke Inhalation (Carbon Monoxide & Cyanide) & Heat Illness

15 Chapter 14: Pediatric Toxicological, Environmental & Endocrine Emergencies

14.1 Common Pediatric Toxic Ingestions, Poisonings & Antidotes 14.2 Diabetic Ketoacidosis (DKA) & Environmental Emergencies (Submersion, Hypothermia) 14.3 Button Battery & Foreign-Body Ingestions, Bites & Envenomations, and Hazardous-Material Exposures

16 Chapter 15: Pediatric Metabolic & Hematologic Emergencies

15.1 Anemia, Sickle Cell Disease, Coagulopathies & Blood Product Administration 15.2 Oncologic Emergencies, Acute Kidney Injury & Pediatric Electrolyte Crises

11.3 Pediatric Acute Respiratory Distress Syndrome (PARDS) & Severe Pneumonia

Key Takeaways Explain This Topic AI

PALICC-2 (2023) defines PARDS by onset within 7 days of a known clinical insult, new unilateral or bilateral opacities consistent with acute parenchymal disease, respiratory failure not fully explained by cardiac failure or fluid overload, and oxygenation impairment (OI ≥ 4 or OSI ≥ 5 on invasive ventilation).

The Oxygenation Index (OI = [Mean Airway Pressure × FiO2 × 100] / PaO2) incorporates distending airway pressure; PALICC-2 stratifies invasively ventilated PARDS, at least 4 hours after diagnosis, as mild/moderate (OI < 16 or OSI < 12) or severe (OI ≥ 16 or OSI ≥ 12).

PALICC-2 lung-protective ventilation uses physiologic tidal volumes of 6–8 mL/kg (4–6 mL/kg if plateau or driving pressure limits are exceeded), plateau pressure ≤ 28 cmH2O (≤ 32 with reduced chest wall compliance), driving pressure ≤ 15 cmH2O, PEEP titrated to oxygenation and hemodynamics, and permissive hypercapnia to a pH of at least 7.20.

For refractory hypoxemia, options include neuromuscular blockade when sedation alone is inadequate, prone positioning (not recommended routinely by PALICC-2), and inhaled nitric oxide, which PALICC-2 reserves for documented pulmonary hypertension, severe right ventricular dysfunction, or rescue and bridge to ECMO.

Parapneumonic effusions and empyema requiring pre-transport chest tube thoracostomy must NEVER be clamped during aeromedical transport; trapped gas expansion at altitude according to Boyle's law will rapidly precipitate a fatal tension pneumothorax.

Last updated: September 2026

Pediatric Acute Respiratory Distress Syndrome (PARDS) and Severe Pneumonia

Pediatric Acute Respiratory Distress Syndrome (PARDS) represents a catastrophic manifestation of acute hypoxemic respiratory failure resulting from direct or indirect alveolar-capillary membrane injury. Characterized by severe non-cardiogenic pulmonary edema, surfactant inactivation, microvascular thrombosis, and severe ventilation-perfusion mismatch, PARDS demands advanced critical care transport management. Interfacility teams must master diagnostic stratification, lung-protective mechanical ventilation, aeromedical gas law implications, and rescue modalities.

Defining PARDS: The PALICC-2 Consensus Framework

In 2023, the Pediatric Acute Lung Injury Consensus Conference (PALICC-2) updated the diagnostic criteria for PARDS across four core domains:

Timing: Clinical onset within 7 days of a recognized clinical insult (e.g., pneumonia, sepsis, aspiration, major trauma, near-drowning, severe burns, pancreatitis).

Chest Imaging: New unilateral or bilateral opacities on chest radiograph or CT, consistent with acute pulmonary parenchymal disease and not due primarily to atelectasis or pleural effusion. Unlike the adult Berlin definition, bilateral disease is not required.

Origin of Edema: Acute respiratory failure not fully explained by left ventricular heart failure or fluid overload . If doubt exists, echocardiography or invasive hemodynamic monitoring must exclude primary hydrostatic pulmonary edema.

Oxygenation Impairment: On invasive ventilation, OI ≥ 4 or OSI ≥ 5 . On non-invasive ventilation (full-face mask CPAP or BiPAP of at least 5 cmH2O), P/F ≤ 300 or S/F ≤ 250 . PALICC-2 also recognizes 'possible PARDS' and 'at risk for PARDS' categories, for example children on nasal high-flow support. Children with perinatal lung disease are excluded.

  • Oxygenation Metrics: Oxygenation Index (OI) and Oxygen Saturation Index (OSI)
  • Mathematical Derivations and Physiological Rationale

While adult ARDS (Berlin definition) relies upon the P a O 2 / F i O 2 PaO_2/FiO_2 P a O 2 ​ / F i O 2 ​ (P/F) ratio, pediatric critical care consensus recognizes that the P/F ratio ignores Mean Airway Pressure ( P a w P_{aw} P a w ​ or MAP) . In pediatric respiratory physiology, oxygenation is intimately linked to the continuous distending pressure maintaining alveolar recruitment. A child achieving a P a O 2 PaO_2 P a O 2 ​ of 70 mmHg on 100% FiO2 with a P a w P_{aw} P a w ​ of 8 cmH 2 O 8\text{ cmH}_2\text{O} 8 cmH 2 ​ O has substantially milder lung injury than a child requiring a P a w P_{aw} P a w ​ of 22 cmH 2 O 22\text{ cmH}_2\text{O} 22 cmH 2 ​ O to attain that identical P a O 2 PaO_2 P a O 2 ​ .

The Oxygenation Index (OI) quantifies this relationship: O I = P a w × F i O 2 × 100 P a O 2 OI = \frac{P_{aw} \times FiO_2 \times 100}{PaO_2} O I = P a O 2 ​ P a w ​ × F i O 2 ​ × 100 ​

P a w P_{aw} P a w ​ : Mean Airway Pressure in cmH 2 O \text{cmH}_2\text{O} cmH 2 ​ O

F i O 2 FiO_2 F i O 2 ​ : Fraction of inspired oxygen (expressed as a fraction between 0.21 and 1.0, multiplied by 100 to yield a percentage)

P a O 2 PaO_2 P a O 2 ​ : Arterial partial pressure of oxygen in mmHg \text{mmHg} mmHg obtained from an arterial blood gas

Non-Invasive Alternative: Oxygen Saturation Index (OSI)

When an indwelling arterial catheter is absent, the Oxygen Saturation Index (OSI) provides a validated non-invasive surrogate, provided pulse oximetry saturation ( S p O 2 SpO_2 Sp O 2 ​ ) is ≤ 97% (above 97%, the oxyhemoglobin dissociation curve flattens, decoupling S p O 2 SpO_2 Sp O 2 ​ from changes in P a O 2 PaO_2 P a O 2 ​ ): O S I = P a w × F i O 2 × 100 S p O 2 OSI = \frac{P_{aw} \times FiO_2 \times 100}{SpO_2} OS I = Sp O 2 ​ P a w ​ × F i O 2 ​ × 100 ​

PALICC-2 Severity Stratification (Invasive Ventilation)

PALICC-2 stratifies severity at least 4 hours after the initial diagnosis into two groups:

  • Mild/moderate PARDS: OI < 16 (or OSI < 12)
  • Severe PARDS: OI ≥ 16 (or OSI ≥ 12)

(The original 2015 PALICC used three tiers: mild 4 to under 8, moderate 8 to under 16, and severe 16 or higher. Older references still use them.)

Lung-Protective Mechanical Ventilation in Transport

The overarching objective of transport ventilation in PARDS is to prevent Ventilator-Induced Lung Injury (VILI) , which comprises volutrauma (alveolar overdistension), barotrauma (excessive transpulmonary pressure), atelectotrauma (shear stress from cyclic end-expiratory alveolar collapse and reopening), and biotrauma (inflammatory cytokine liberation into the systemic circulation).

Core Ventilator Strategy & Targets

Physiologic Tidal Volume: PALICC-2 recommends tidal volumes in the physiologic range of 6 to 8 mL/kg of predicted (ideal) body weight , reduced to 4 to 6 mL/kg when needed to keep plateau and driving pressures within limits.

Plateau Pressure ( P p l a t P_{plat} P pl a t ​ ) Limits: Maintain P p l a t ≤ 28 cmH 2 O P_{plat} \le 28\text{ cmH}_2\text{O} P pl a t ​ ≤ 28 cmH 2 ​ O in patients with normal chest wall compliance. In patients with reduced chest wall compliance (e.g., severe abdominal compartment syndrome, extensive burns, severe scoliosis), limit P p l a t ≤ 32 cmH 2 O P_{plat} \le 32\text{ cmH}_2\text{O} P pl a t ​ ≤ 32 cmH 2 ​ O . Keep driving pressure ( Δ P = P p l a t − P E E P \Delta P = P_{plat} - PEEP Δ P = P pl a t ​ − PEEP ) strictly < 15 cmH2O .

Moderate-to-High PEEP Titration: Utilize pediatric PEEP/FiO2 titration grids. Adequate PEEP prevents atelectotrauma by stenting open unstable alveoli throughout expiration. In moderate-to-severe PARDS, PEEP is typically titrated between 10 and 15+ cmH2O , balanced against cardiac index and venous return.

Permissive Hypercapnia: Avoid escalating minute ventilation to chase normocapnia. PALICC-2 accepts respiratory acidosis down to a pH of about 7.20 in order to stay within pressure and volume limits.

Absolute Contraindications to Permissive Hypercapnia: Traumatic brain injury with intracranial hypertension, severe pulmonary hypertension, and severe myocardial depression.

Refractory Hypoxemia Rescues: Neuromuscular Blockade, Proning, and Inhaled Nitric Oxide

When hypoxemic failure progresses despite lung-protective ventilation, transport teams deploy specialized rescue strategies:

Neuromuscular Blockade in Transit

Continuous infusion or intermittent boluses of neuromuscular blocking agents (e.g., Cisatracurium 0.1–0.2 mg/kg IV or Vecuronium/Rocuronium ) eliminate patient-ventilator dyssynchrony, abolish active exhalation against the mechanical breath, decrease systemic oxygen consumption (VO2), and optimize chest wall compliance during flight.

Prone Positioning Mechanics & Aeromedical Logistics

PALICC-2 does not recommend prone positioning as routine therapy, but it may be considered as a rescue in severe PARDS. Placing the child in the prone position (for 12 to 16 hours/day ) redistributes transpulmonary pressure gradients, recruits dorsal atelectatic alveoli, uncompresses dependent lung segments from the overlying heart and abdominal viscera, and dramatically improves V / Q V/Q V / Q matching. During interfacility transport, prone positioning can be safely maintained provided the endotracheal tube is scrupulously secured, pressure points and eyes are padded, and inline suctioning is accessible.

Inhaled Nitric Oxide (iNO): Selective Pulmonary Vasodilation

Indications: PALICC-2 does not recommend routine iNO in PARDS. It may be considered for documented pulmonary hypertension or severe right ventricular dysfunction, and as a rescue or bridge to ECMO in severe cases.

Dosing: Administer 10 to 20 ppm delivered directly into the inspiratory limb of the transport ventilator circuit via specialized delivery consoles (e.g., INOmax).

Mechanism: Inhaled nitric oxide is an uncharged, lipid-soluble gas that diffuses across alveolar membranes into adjacent vascular smooth muscle. It stimulates soluble guanylyl cyclase, generating cyclic guanosine monophosphate (cGMP) and producing potent vasodilation strictly in ventilated alveolar units.

Selective Action: Because iNO is rapidly scavenged and inactivated by hemoglobin in the pulmonary capillary lumen (forming methemoglobin and nitrate), it does not reach the systemic circulation and causes zero systemic hypotension . By selectively dilating vessels adjacent to well-ventilated alveoli, it redirects blood flow away from non-ventilated, consolidated lung zones, slashing intrapulmonary shunt fraction and serving as a critical transport bridge to Extracorporeal Membrane Oxygenation (ECMO).

ECMO Referral: PALICC-2 recommends considering ECMO in severe PARDS when lung-protective strategies fail and the cause is potentially reversible. It does not set a single OI cutoff, although an OI around 40 is a traditional trigger for referral. Refer early so the child can still be moved safely (Section 6.6).

Severe Pediatric Pneumonia and Pleural Space Complications

Severe pediatric pneumonia can act as the primary trigger for PARDS or present with severe unilateral consolidation and parapneumonic collections.

Microbial Etiologies:

Bacterial: Streptococcus pneumoniae (most common overall); Staphylococcus aureus (especially community-acquired MRSA expressing the Panton-Valentine leukocidin [PVL] toxin, causing rapid necrotizing pneumonia, cavitary lung abscesses, pneumatoceles, and massive hemoptysis); Group A Streptococcus .

Viral: RSV, influenza A/B, adenovirus, metapneumovirus.

Atypical: Mycoplasma pneumoniae , Chlamydia pneumoniae .

Parapneumonic Effusion & Empyema: Fluid progression from simple sterile exudate to fibrinopurulent loculation. Physical exam demonstrates dullness to percussion, asymmetric chest expansion, absent breath sounds, and tracheal deviation.

Transport Management of Chest Tubes & Boyle's Law

Large pleural effusions compromising ventilation must undergo drainage (pigtail catheter or chest tube thoracostomy) prior to transport departure.

Transport Safety: Chest Tube Management Under Boyle's Law

Boyle's Law ( P 1 V 1 = P 2 V 2 P_1 V_1 = P_2 V_2 P 1 ​ V 1 ​ = P 2 ​ V 2 ​ ): As transport aircraft ascend and atmospheric pressure drops, trapped gas pockets expand inversely.

NEVER CLAMP A CHEST TUBE IN TRANSIT! Clamping a chest tube in a patient with a bronchopleural fistula or active air leak will trap expanding air within the pleural space, rapidly transforming an evacuated hemithorax into a fatal tension pneumothorax at cruising altitude.

Drainage System Integrity: Maintain drainage canisters in an upright, dependent position below the patient's thorax at all times. Connect to a functional water seal or one-way Heimlich flutter valve to ensure continuous egress of expanding air and fluid.

Severity Stratification & Ventilatory Benchmarks in PARDS

Severity (PALICC-2, invasive) Oxygenation Index (OI) Oxygen Saturation Index (OSI) Tidal Volume Pressure Limits Transport Priorities

Mild/moderate PARDS 4 to under 16 5 to under 12 6–8 mL/kg PBW (4–6 if limits exceeded) Pplat ≤ 28 cmH2O; driving pressure ≤ 15 cmH2O PEEP to oxygenation and hemodynamics, sedation, avoid hyperoxia

Severe PARDS 16 or higher 12 or higher Often 4–6 mL/kg Pplat ≤ 28 cmH2O (≤ 32 with a stiff chest wall) Neuromuscular blockade if needed; consider prone positioning and iNO as rescue

Refractory hypoxemia Rising despite optimal care (about 40 is a traditional trigger) — Rest settings once on ECMO — Early ECMO center referral or mobile ECMO

Realistic Transport Scenario: Transport of Severe Necrotizing PARDS to an ECMO Center

A neonatal-pediatric critical care transport team is dispatched via pressurized fixed-wing aircraft to transport a 4-year-old male (weight 16 kg) with severe necrotizing MRSA pneumonia. The child was intubated 12 hours prior and is failing conventional ventilation at the community hospital. Ventilator settings: Pressure Control mode, PIP 32 cmH2O, PEEP 14 cmH2O, Mean Airway Pressure ( P a w P_{aw} P a w ​ ) 20 cmH2O, FiO2 1.0, RR 28 bpm. Radial arterial blood gas demonstrates: pH 7.22, PaCO2 58 mmHg, PaO2 50 mmHg, and HCO3 23 mEq/L.

The transport physician calculates the Oxygenation Index (OI) : O I = 20 × 1.0 × 100 50 = 2 , 000 50 = 40.0 OI = \frac{20 \times 1.0 \times 100}{50} = \frac{2,000}{50} = 40.0 O I = 50 20 × 1.0 × 100 ​ = 50 2 , 000 ​ = 40.0

Recognizing severe PARDS at a level that traditionally triggers ECMO referral (OI about 40), the team immediately initiates multimodal transport stabilization:

Neuromuscular Blockade: Administers cisatracurium IV bolus followed by continuous infusion to eliminate ventilator dyssynchrony.

Lung-Protective Adjustments: Transitions to Volume Control with guaranteed low tidal volume of 70 mL (4.4 mL/kg PBW), sets PEEP at 15 cmH2O, limiting P p l a t P_{plat} P pl a t ​ to 27 cmH2O, and embracing permissive hypercapnia.

Inhaled Nitric Oxide (iNO): Initiates iNO at 20 ppm inline with the transport ventilator. Within 20 minutes, PaO2 improves from 50 to 78 mmHg, reducing the calculated OI to 25.6.

Prone Transport Preparation: The team carefully positions the child prone on the aircraft transport stretcher with head aligned, chest rolls placed, and the ETT taped securely. Throughout the 2-hour flight at a cabin altitude of 4,000 feet, the patient maintains SpO2 91%–93%, arriving stably at the regional pediatric ECMO center without cardiac arrest.

Clinical Pearls for PARDS and Severe Pediatric Pneumonia

Important

The Significance of Mean Airway Pressure in OI: Never calculate oxygenation impairment using the P/F ratio alone in ventilated children. The Oxygenation Index ( O I = [ P a w × F i O 2 × 100 ] / P a O 2 OI = [P_{aw} \times FiO_2 \times 100] / PaO_2 O I = [ P a w ​ × F i O 2 ​ × 100 ] / P a O 2 ​ ) accounts for the distending airway pressure ( P a w P_{aw} P a w ​ ) required to achieve that arterial oxygenation. An O I ≥ 16 OI \ge 16 O I ≥ 16 defines Severe PARDS.

Tip

Selective Micro-Vasodilation of iNO: Inhaled nitric oxide (10–20 ppm) dilates pulmonary vasculature only in ventilated lung units, shunting blood flow away from non-ventilated consolidations without inducing systemic hypotension. Use it as a transport bridge in refractory hypoxemia.

Warning

Never Clamp a Chest Tube in Flight: As barometric pressure decreases at altitude, Boyle's law ( P 1 V 1 = P 2 V 2 P_1 V_1 = P_2 V_2 P 1 ​ V 1 ​ = P 2 ​ V 2 ​ ) dictates that trapped air pockets expand. Clamping a chest tube in a patient with a bronchopleural fistula will cause rapid development of a fatal tension pneumothorax.

Loading diagram... PALICC-2 PARDS Oxygenation Index & Transport Resuscitation Algorithm